Blood and guts: how the intestinal microbiome shapes hematopoiesis and treatment of hematologic disease
Abstract
Spread awareness by sharing and learning more: Post the social media graphic, Listen to past conference sessions, and this webinar. Find these and other opportunities here: Caregiver Health and Wellness section.
Abstract
Key Points
Key Points
The number of autoHCT and alloHCT grew faster in Non-Hispanic African Americans and Hispanics compared to Non-Hispanic Whites.
Survival after autoHCT and alloHCT improved over time for all racial/ ethnic groups, though African Americans have worse outcomes.
Dr. Nicolai Podoltsev describes options available for patients with PNH who could choose non-transplant treatments.
Lisa Barbarotta describes techniques to help manage low blood counts in this session.
Zahra Pakbaz MD is a board certified hematologist and associate clinical professor. in collaboration with her other team members, Dr Pakbaz provides comprehensive care for hematological disorders including
Dr. Ball received his medical degree at Georgetown University in Washington, DC, then continued his training at Yale-New Haven Hospital and Memorial Sloan Kettering Cancer Center in New York City. At Yale, he co-directed the school’s Refugee Health Clinic. He’s earned numerous honors and awards, including being selected as chief fellow at Memorial Sloan Kettering and Yale’s coveted Global Health Scholar program enabling him to study in South Africa.